EUVIMEDEUVIMED entdecken
Open Access

Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties

Jacob Marthinsen Seefeldt iD, Casper Homilius iD, Jakob Hansen iD, Thomas Ravn Lassen iD, Nichlas Riise Jespersen iD, Rebekka Vibjerg Jensen iD, Ebbe Boedtkjer iD, Hans Erik Bøtker iD, Roni Nielsen iD

Journal of the American Heart Association · 07.05.2024 · 13 (9)

DOI: 10.1161/jaha.123.033744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.05.2024. Verfasst von Jacob Marthinsen Seefeldt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine Aarhus University Aarhus Denmark. Hauptthemen laut MEDLINE: Myocardial Contraction, Ventricular Function, Left, Vasodilation, Cardiotonic Agents. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The heart can metabolize the microbiota‐derived short‐chain fatty acid butyrate. Butyrate may have beneficial effects in heart failure, but the underlying mechanisms are unknown. We tested the hypothesis that butyrate elevates cardiac output by mechanisms involving direct stimulation of cardiac contractility and vasorelaxation in rats. Methods and Results We examined the effects of butyrate on (1) in vivo hemodynamics using parallel echocardiographic and invasive blood pressure measurements, (2) isolated perfused hearts in Langendorff systems under physiological conditions and after ischemia and reperfusion, and (3) isolated coronary arteries mounted in isometric wire myographs. We tested Na‐butyrate added to injection solutions or physiological buffers and compared its effects with equimolar doses of NaCl. Butyrate at plasma concentrations of 0.56 mM increased cardiac output by 48.8±14.9%, stroke volume by 38.5±12.1%, and left ventricular ejection fraction by 39.6±6.2%, and lowered systemic vascular resistance by 33.5±6.4% without affecting blood pressure or heart rate in vivo. In the range between 0.1 and 5 mM, butyrate increased left ventricular systolic pressure by up to 23.7±3.4% in isolated perfused hearts and by 9.4±2.9% following ischemia and reperfusion, while reducing myocardial infarct size by 81.7±16.9%. Butyrate relaxed isolated coronary septal arteries concentration dependently with an EC 50 =0.57 mM (95% CI, 0.23–1.44).

Conclusions

We conclude that butyrate elevates cardiac output through mechanisms involving increased cardiac contractility and vasorelaxation. This effect of butyrate was not associated with adverse myocardial injury in damaged hearts exposed to ischemia and reperfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial ContractionVentricular Function, LeftVasodilationCardiotonic AgentsButyratesVasodilator AgentsAnimalsMaleIsolated Heart PreparationRatsMyocardial Reperfusion InjuryCardiac OutputStroke VolumeRats, WistarCoronary VesselsDose-Response Relationship, DrugDisease Models, AnimalRats, Sprague-Dawley

Stichwörter der Autor:innen

butyratecontractile functionhemodynamicsmetabolismshort‐chain fatty acidsvasorelaxation

Substanzen

Cardiotonic AgentsButyratesVasodilator Agents

Autor:innen und Institutionen

  • Department of Clinical Medicine Aarhus University Aarhus Denmark.
  • Department of Cardiology Aarhus University Hospital Aarhus Denmark.
  • Department of Biomedicine Aarhus University Aarhus Denmark.
  • Department of Forensic Medicine Aarhus University Hospital Aarhus Denmark.

ORCID-Profile: Jacob Marthinsen Seefeldt, Casper Homilius, Jakob Hansen, Thomas Ravn Lassen, Nichlas Riise Jespersen, Rebekka Vibjerg Jensen, Ebbe Boedtkjer, Hans Erik Bøtker, Roni Nielsen

Zitieren

APA

Seefeldt, J. M., Homilius, C., Hansen, J., Lassen, T. R., Jespersen, N. R., Jensen, R. V., Boedtkjer, E., Bøtker, H. E., & Nielsen, R. (2024). Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties. Journal of the American Heart Association, 13(9). https://doi.org/10.1161/jaha.123.033744

Vancouver

Seefeldt JM, Homilius C, Hansen J, Lassen TR, Jespersen NR, Jensen RV, et al. Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties. Journal of the American Heart Association. 2024;13(9). doi:10.1161/jaha.123.033744

BibTeX
@article{Seefeldt2024,
  author = {Seefeldt, Jacob Marthinsen and Homilius, Casper and Hansen, Jakob and Lassen, Thomas Ravn and Jespersen, Nichlas Riise and Jensen, Rebekka Vibjerg and Boedtkjer, Ebbe and Bøtker, Hans Erik and Nielsen, Roni},
  title = {Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {9},
  doi = {10.1161/jaha.123.033744}
}
Kostenlos starten →